MiMedx Group Inc (MDXG)
7.68
+0.07
(+0.92%)
USD |
NASDAQ |
Mar 28, 16:00
7.685
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Total Liabilities (Quarterly): 96.33M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 96.33M |
September 30, 2023 | 187.69M |
June 30, 2023 | 189.04M |
March 31, 2023 | 186.10M |
December 31, 2022 | 189.42M |
September 30, 2022 | 192.32M |
June 30, 2022 | 182.27M |
March 31, 2022 | 181.88M |
December 31, 2021 | 187.85M |
September 30, 2021 | 186.33M |
June 30, 2021 | 194.28M |
March 31, 2021 | 198.86M |
December 31, 2020 | 202.18M |
September 30, 2020 | 200.45M |
June 30, 2020 | 128.05M |
March 31, 2020 | 128.57M |
December 31, 2019 | 132.77M |
September 30, 2019 | 139.69M |
June 30, 2019 | 145.63M |
March 31, 2019 | 69.09M |
December 31, 2018 | 73.19M |
December 31, 2017 | 47.46M |
September 30, 2017 | 36.24M |
June 30, 2017 | 52.60M |
March 31, 2017 | 59.46M |
Date | Value |
---|---|
December 31, 2016 | 60.26M |
September 30, 2016 | 58.39M |
June 30, 2016 | 55.45M |
March 31, 2016 | 62.98M |
December 31, 2015 | 27.92M |
September 30, 2015 | 25.40M |
June 30, 2015 | 20.60M |
March 31, 2015 | 19.70M |
December 31, 2014 | 19.93M |
September 30, 2014 | 16.06M |
June 30, 2014 | 11.54M |
March 31, 2014 | 11.11M |
December 31, 2013 | 11.13M |
September 30, 2013 | 9.758M |
June 30, 2013 | 7.392M |
March 31, 2013 | 6.259M |
December 31, 2012 | 15.18M |
September 30, 2012 | 14.35M |
June 30, 2012 | 11.80M |
March 31, 2012 | 14.36M |
December 31, 2011 | 15.20M |
September 30, 2011 | 11.70M |
June 30, 2011 | 11.36M |
March 31, 2011 | 11.04M |
December 31, 2010 | 1.252M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
69.09M
Minimum
Mar 2019
202.18M
Maximum
Dec 2020
165.94M
Average
186.22M
Median
Total Liabilities (Quarterly) Benchmarks
TELA Bio Inc | 59.17M |
Amylyx Pharmaceuticals Inc | 84.02M |
CEL-SCI Corp | 16.06M |
AIM ImmunoTech Inc | 5.259M |
IGC Pharma Inc | 2.206M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 239.05M |
Shareholders Equity (Quarterly) | 142.72M |
Debt to Equity Ratio | 0.337 |
Current Ratio | 3.570 |
Net Debt Paydown Yield | 0.01% |